Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Reserpine (N1867): Lab Protocols and QC for Neuropharmacolog

    2026-04-30

    Reserpine (N1867): Technical Guidance for Laboratory Neuropharmacology Workflows

    What This Product Solves

    Reserpine (CAS No. 50-55-5), also referenced as 3,20-Yohimban-16-carboxylic acid, is a bioactive natural product extracted from Rauvolfia species. Supplied by APExBIO at >98.8% purity, Reserpine is a consistent small-molecule standard for experimental models investigating neurotransmitter depletion, antihypertensive mechanisms, and neuropharmacology pathways (product_spec). Its chemical stability, validated solubility profile, and controlled shipping conditions make it suitable for workflows demanding reproducibility and high analytical confidence. Reserpine is not intended for clinical, diagnostic, or veterinary applications, and its use is restricted to research settings.

    Typical use cases include depletion of monoamine neurotransmitters, exploration of hypertension pathways, and modulation of dopamine and serotonin signaling in preclinical models. The compound's workflow value is primarily its reliability in supporting studies where neurotransmitter pool manipulation is required under defined conditions.

    Protocol Parameters

    • assay: Stock solution preparation | value_with_unit: ≥13 mg/mL in DMSO (with gentle warming) | applicability: All in vitro and ex vivo workflows requiring concentrated parent stock | rationale: Ensures complete dissolution and consistent dosing; avoids precipitation-related assay artifacts | source_type: product_spec
    • assay: Storage of solid compound | value_with_unit: -20°C, sealed, dry, and cool | applicability: Long-term inventory for batch-to-batch reproducibility | rationale: Maintains chemical integrity; minimizes degradation risk | source_type: product_spec
    • assay: Solution stability | value_with_unit: Use freshly prepared solutions; avoid long-term storage | applicability: All experimental workflows using Reserpine in solution | rationale: Prevents activity loss from hydrolysis or oxidation; supports reproducible results | source_type: product_spec
    • assay: HPLC and NMR purity confirmation | value_with_unit: >98.8% purity | applicability: Reference standard for quantitative and qualitative research | rationale: Minimizes confounding effects from impurities | source_type: product_spec

    Workflow Setup and QC Checklist

    • Upon receipt, inspect the packaging and confirm shipment with blue ice to verify temperature control during transit (source: product_spec).
    • Transfer the vial immediately to a -20°C freezer, ensuring it remains sealed and protected from moisture and light exposure.
    • Prepare DMSO stock solutions at concentrations ≥13 mg/mL using gentle warming if required. Visually confirm complete dissolution before aliquoting.
    • Aliquot stock solutions to minimize freeze-thaw cycles and reduce contamination risk.
    • Discard any unused working solutions; do not store diluted Reserpine for extended periods as per workflow recommendations (internal_article).
    • Document batch number, preparation date, and storage conditions in laboratory records for traceability.
    • Utilize validated analytical methods (e.g., HPLC, NMR) to periodically verify compound purity if stored for several months.

    Common Failure Modes and Fixes

    • Dissolution failure in DMSO: If precipitation is observed, increase temperature gently and extend mixing time. Do not substitute with water or ethanol, as Reserpine is insoluble in these solvents (product_spec).
    • Loss of activity after storage: Prepare working solutions fresh for each experiment. If unexpected results occur, check for signs of oxidation or turbidity; discard compromised solutions (internal_article).
    • Batch-to-batch inconsistency: Always use high-purity Reserpine from traceable sources and maintain consistent storage and handling procedures.
    • Assay interference from solvent: Minimize DMSO concentration in final assays to avoid cytotoxicity or solvent effects on target cells or tissues.
    • Compound degradation: Avoid repeated freeze-thaw cycles and exposure to light or air. If long-term storage is unavoidable, verify compound integrity by analytical QC before use.

    Scope and Limitations

    Reserpine (N1867) is formulated for research use only and is not validated for diagnostic, therapeutic, or veterinary applications. Its use is best suited to neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research where reliable compound performance is required. Limitations include poor solubility in aqueous and alcoholic solvents, rapid degradation in solution, and workflow dependency on DMSO as a carrier. The compound should not be used in protocols requiring long-term solution stability, clinical dosing, or untested model systems. For further workflow integration details, see the internal article "Reserpine in Neurotransmitter Depletion Research: Optimized Protocols", which addresses protocol enhancements and troubleshooting strategies for this compound.

    Conclusion

    High-purity Reserpine (SKU N1867) from APExBIO is a robust reagent for controlled neurotransmitter depletion and hypertension pathway studies, provided its solubility and storage parameters are strictly observed. By adhering to validated preparation and QC workflows, researchers can achieve reproducible, high-quality results in neuropharmacology research. Avoid using Reserpine in applications beyond its defined research scope, and always follow best practices for compound handling and solution preparation to minimize variability and maximize data integrity.